Clinical trials: TACE

HepatoCellular Carcinoma

Comparison of SBRTand Repeat TACE for HCC

• Unknown status
• Age: 18 to 80 years
• Surgery or procedure

Comparison of Stereotactic Body Radiation Therapy (SBRT) and repeated transarterial chemoembolization (TACE) for Hepatocellular Carcinoma (HCC)as a Local Salvage Treatment after first incomplete TACE

Trial name

STH (NCT03326375)

Testing

SBRT

Where

South Korea

Volunteers

80 people, healthy volunteers welcome

Sponsor

Gangneung Asan Hospital